We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Please watch the video for more information
days to go: Expired investment: £1,579,480
Movem is a platform where tenants, landlords and agencies have been sharing their rental experiences since 2013. Building a digital rental profile known as a Movem Passport. Landlords and agents can pay to instantly download a tenant's full reference, designed to be quicker, cheaper and less open to fraud.
days to go: Expired investment: £395,580
Nayanacare is a mobile and pc app that allows individual customers to make the right choice of care services and carers quick and easy. Care suppliers can reduce costs by using Nayanacare as a dedicated marketing platform and take advantage of the platforms business management capabilities.
days to go: Expired investment: £76,030
C-Major is a medical technology company. It asserts that over 2 million people suffer a Needle Stick Injury (NSI) every year and are at risk of contracting blood-borne viruses such as Hepatitis and HIV. It aspires to resolve this crisis by bringing to market its patented medical device, Controlled Helical Retraction Device, to prevent NSIs. The company argues that the device contains a ‘Helical Track’ mechanism for controlled acceleration of the needle during retraction as well as a ‘Sealed Port’ to minimise any blood splatter. C-Major endeavours to disrupt the $5.5 billion safety syringe market with its product. It is backed by the UK 'Innovation Seed' fund. C-Major will use the investment to complete the final design of its product for manufacture and assembly ahead of a Series A funding round in 2021.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £211,595
The go-to platform for people planning the most important purchase of their lives: a new home.
days to go: Expired investment: £103,008
Jupiter Diagnostics provide a patent-protected portable reader and test card to provide reliable and cost-effective blood results. Each test card has the ability to measure multiple tests from a prick of blood from the finger and can deliver laboratory-quality results in just ten minutes.
days to go: Expired investment: £2,005,050
Rebel Book Club is a developing subscription business of six hundred members who have read fifty-two books in four years. It delivers one non-fiction book every month and hosts a secret meetup featuring a book-inspired cocktail. The company has 600+ paying members in London, Bristol and Oxford, etc. and it receives 130+ average number of new applications monthly. The company hosts meetups at Entrepreneur First, Airbnb HQ, and WeWork. Rebel Book Club has collaborated with authors Matthew Syed (Rebel ideas), Kate Raworth (Doughnut Economics), Seth Godin (This is Marketing) and many more. The company aims to make the world's best non-fiction book club by growing a membership experience, build a reach code and support literacy projects.
days to go: Expired investment: £148,070
One Year No Beer (OYNB) is a community support platform that helps people change their relationship with alcohol. It argues that despite drinking being a part and parcel of most work, social and family gatherings, excess drinking leads to 3 million deaths per year, causes 5.1% of all diseases and costs £52 billion to the UK economy alone. OYNB intends to change this by helping customers choose a plan from its subscription-based models that consist of a 28-day, 90-day and 365-day challenge to stay away from alcohol. The platform has empowered 80,000+ people in 90 countries through its challenges, earned revenue worth £2.2 million in 2020, and witnessed an 85% growth in Alcohol-Free Challenge (AFC) sales between February - June 2021. OYNB has featured in the BBC, ITV, and Men’s Health, to name a few. It also has an online presence of 230,000+ social media followers. The company states it will use the investment to consolidate its growth and improve its technology to become a stronger brand and reach millions globally.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £932,654
Carocell Bio is an early-stage Research and Design (R&D) company aiming to develop nanoparticle-based, novel peptide anti-inflammatories to treat atopic dermatitis/eczema (AD) and other serious inflammatory diseases. It argues that millions of people continue to be affected by debilitating skin ailments, which in turn, escalates the development of new pharmaceutical drugs. The company asserts that the anti-inflammatory therapeutics market will reach US$122.6 billion by 2025 from US$95.9 billion in 2019. The company aims to be a major contender in this market. Carocell Bio has also been awarded an Innovate UK grant of £390,874. The company is seeking £1 million in equity investment over the next 12 months to show that their compounds work in human tissue biopsies of several inflammatory diseases.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Molecular Warehouse are trying to create a world where most diseases are prevented by giving people the chance to monitor and manage their helath where ever and whenever. Molecular Warehouse have developed a platform that allows anyone to test themselves at any time.
days to go: Expired investment: £737,480
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph